Carbohydrate-deficient glycoprotein syndrome (CDGS) is a newly delineated g
roup of inherited multisystemic disorders associated with abnormal glycosyl
ation of a number of serum glycoproteins. Several types have been described
on the basis of clinical presentation and biochemical changes of the glyco
sylation of serum transferrin and attributed to different enzymatic defects
, their clinical presentations are fully different and a clinical heterogen
eity is observed within a same type of CDGS. Patients with CDGS type la usu
ally present with neurologic (hypotonia, strabismus and cerebellar hypoplas
ia) and cutaneous (inverted nipples, abnormal distribution of adipose tissu
e) abnormalities, together with multivisceral involvement (digestive, hepat
ic, cardiac, renal). However, neurologic and cutaneous symptoms may be abse
nt, so that CDGS must be looked for in case of unexplained organ failure su
ch as isolated liver insufficiency; cardiomyopathy: pericarditis, tubulopat
hy, nephrotic syndrome, vascular accident or retinitis pigmentosa. Patients
with CDGS type Ib present with liver disease, enteropathy and hypoglycemia
without neurologic involvement. These patients are successfully treated wi
th oral mannose administration, emphasizing the importance of making the di
agnosis. Patients with CDGS type Ic present with mild psychomotor retardati
on and seizures. Patients with CDGS type II have psychomotor retardation as
sociated with severe gastrointestinal disorder dysmorphic features and abno
rmal electroretinogram. Other types (III, IV) are less clearly defined and
the clinical presentation includes convulsive encephalopathy. Biological ab
normalities such as mild hepatic cytolysis, hematologic and hormonal abnorm
alities are consistently observed in CDGS type I, as well as renal hyperech
ogeneity, leading one to look for this syndrome when they are associated. U
ntil now, only four enzymatic deficiencies have been identified (types la,
Ib, Ic, II). (C) 2000 Editions scientifiques et medicales Elsevier SAS.